William Shaw, PhD and Sidney Baker, MD discuss their research, hosted by Autism Research Coalition – 2 of 2
William Shaw, PhD
March 29, 2021
Overview
As noted in the publication, “Escalation of the dose of itraconazole resulted in a complete loss of all symptoms of Autism over the course of 3 months. This rapid complete reversal of Autism is consistent with several articles proposing mold in general and Aspergillus specifically as a potential major cause of Autism.”
About the Author
William Shaw, PhD
Dr. Sidney Baker was the co-founder of Defeat Autism Now!, a national organization devoted to dialog among parents, practitioners and scientists regarding biomedical treatment options and the environmental origins of the current Autism epidemic. He received his undergraduate, medical, and medical postgraduate training from Yale University where he served as Chief Resident in Pediatrics on the full-time medical faculty. He is the author of multiple books and publications and was the 1999 recipient of the Linus Pauling Award of the Institute for Functional Medicine for his contributions to the development of Functional Medicine, to name a few achievements.
William Shaw, PhD, is board certified in the fields of clinical chemistry and toxicology by the American Board of Clinical Chemistry. Before he founded The Great Plains Laboratory, Inc., Dr. Shaw worked for the Centers for Disease Control and Prevention (CDC), Children’s Mercy Hospital, University of Missouri at Kansas City School of Medicine, and Smith Kline Laboratories.
You Might Also Like
View All Webinars
Download a Test Requisition Form (TRF)
Thank you for choosing Mosaic Diagnostics for your testing needs. If you are unable to access the MosaicDX Practitioner Portal and need to download a digital copy of the Test Requisition Form (TRF), you may access the most updated files (see links below.)
Effective March 2, 2026, A $25 processing fee applies to all paper test requisitions received.
Mosaic Diagnostics and Galaxy Diagnostics Partner to Set a New Standard in Lyme and Coinfection Testing
OVERLAND PARK, KS. — June 2, 2025 — Today, Mosaic Diagnostics, the global pioneer in specialty diagnostic testing, announces the launch of a comprehensive Lyme + Co-Infections portfolio through a strategic partnership with Galaxy Diagnostics, a leader in advanced testing for flea and tick-borne pathogens.
As part of this partnership, Mosaic Diagnostics will now offer Galaxy’s full suite of diagnostic tests to its extensive network of integrative and functional medicine providers across the U.S.
Case Study: Rapid Complete Recovery from an Autism Spectrum Disorder after Treatment of Aspergillus with the Antifungal Drugs Itraconazole and Sporanox
Sidney Baker, MD; William Shaw, PhDIMCJ Integrative Medicine • Vol.
Stay Informed, Stay Ahead
Join the MosaicDX community and elevate your testing knowledge.